__NUXT_JSONP__("/drugs/Entospletinib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1229208-44-9",chebiId:b,chemicalFormula:b,definition:"An orally available inhibitor of spleen tyrosine kinase (Syk), with potential antineoplastic activity. Upon oral administration of entospletinib, this agent may inhibit the activity of Syk, which inhibits B-cell receptor (BCR) signaling and leads to an inhibition of tumor cell activation, migration, adhesion and proliferation. Syk, a non-receptor cytoplasmic, BCR-associated tyrosine kinase, is expressed in hematopoietic tissues and is often overexpressed in hematopoeitic malignancies.",fdaUniiCode:"6I3O3W6O3B",identifier:"C105402",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C1967"],synonyms:["6-(1H-Indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine","ENTO","ENTOSPLETINIB",a,"GS 9973","GS-9973","Imidazo(1,2-a)pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-(4-(4-morpholinyl)phenyl)-"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FEntospletinib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Entospletinib","","2021-10-30T13:17:45.543Z")));